A Novel Intronic Variant in FRMPD4 Disrupts Splicing: Case Report of an X‐Linked Neurodevelopmental Disorder
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.64306 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Tomoko Satake und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Genetics, Kanagawa Children's Medical Center, Yokohama, Japan. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders, RNA Splicing, Genetic Diseases, X-Linked. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Ministry of Health, Labour and Welfare, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
FRMPD4 , a gene on the X‐chromosome, encodes a neuronal scaffold protein, and six variants in this gene have been associated with X‐linked neurodevelopmental disorder. We identified a novel intronic hemizygous variant (NM_014728.3:c.1198‐6C>A) in FRMPD4 in a 2‐year‐old male patient with moderate developmental delay inherited from his asymptomatic heterozygous mother. Minigene assays in different cell lines demonstrated that this variant led to the consistent skipping of in‐frame exon 12, which encodes 30 amino acids within the FERM domain. We speculated that this splicing defect may be due to the impaired recruitment of essential splicing factor U2AF2, as this C>A intronic variant is positioned at the center of the uridine‐rich polypyrimidine tract, adjacent to the 3′‐splice site. Structural modeling predicted that the loss of this region would disrupt the integrity of the FERM domain. Given that FRMPD4 mediates metabotropic glutamate receptor signaling via its FERM domain, we conclude that this intronic variant is likely pathogenic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Genetics, Kanagawa Children's Medical Center, Yokohama, Japan.
- Clinical Research Institute, Kanagawa Children's Medical Center, Yokohama, Japan.
ORCID-Profile: Tomoko Satake
Förderung
- Japan Agency for Medical Research and Development
- Ministry of Health, Labour and Welfare
- Japan Society for the Promotion of Science
Zitieren
APA
Satake, T., Kawai, Y., Nagai, K., Naruto, T., & Kuroda, Y. (2025). A Novel Intronic Variant in FRMPD4 Disrupts Splicing: Case Report of an X‐Linked Neurodevelopmental Disorder. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64306
Vancouver
Satake T, Kawai Y, Nagai K, Naruto T, Kuroda Y. A Novel Intronic Variant in FRMPD4 Disrupts Splicing: Case Report of an X‐Linked Neurodevelopmental Disorder. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64306
BibTeX
@article{Satake2025,
author = {Satake, Tomoko and Kawai, Yasuhiro and Nagai, Koki and Naruto, Takuya and Kuroda, Yukiko},
title = {A Novel Intronic Variant in FRMPD4 Disrupts Splicing: Case Report of an X‐Linked Neurodevelopmental Disorder},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.64306}
}
EUVIMED